Cite
Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the –2518 A→G promoter polymorphism.
MLA
Zietz, B., et al. “Caucasian Patients with Type 2 Diabetes Mellitus Have Elevated Levels of Monocyte Chemoattractant Protein-1 That Are Not Influenced by the –2518 A→G Promoter Polymorphism.” Diabetes, Obesity & Metabolism, vol. 7, no. 5, Sept. 2005, pp. 570–78. EBSCOhost, https://doi.org/10.1111/j.1463-1326.2004.00436.x.
APA
Zietz, B., Büchler, C., Herfarth, H., Müller-Ladner, U., Spiegel, D., Schölmerich, J., & Schäffler, A. (2005). Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the –2518 A→G promoter polymorphism. Diabetes, Obesity & Metabolism, 7(5), 570–578. https://doi.org/10.1111/j.1463-1326.2004.00436.x
Chicago
Zietz, B., C. Büchler, H. Herfarth, U. Müller-Ladner, D. Spiegel, J. Schölmerich, and A. Schäffler. 2005. “Caucasian Patients with Type 2 Diabetes Mellitus Have Elevated Levels of Monocyte Chemoattractant Protein-1 That Are Not Influenced by the –2518 A→G Promoter Polymorphism.” Diabetes, Obesity & Metabolism 7 (5): 570–78. doi:10.1111/j.1463-1326.2004.00436.x.